• Carduran Neo 4 mg modified-release tablets

  Form: tablets, modified release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	5,093 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Viatris Healthcare Limited

• Carduran Neo 8 mg modified-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	10,185 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Viatris Healthcare Limited

• Doxazosin Alter 2 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	2 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Laboratorios Alter S.A.

• Doxazosin Alter 4 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Laboratorios Alter S.A.

• Doxazosin Aurovitas 2 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	2,42 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Aurovitas Spain, S.A.U.

• Doxazosin Aurovitas 4 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,84 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Aurovitas Spain, S.A.U.

• Doxazosin CINFA 2 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN	2 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Laboratorios Cinfa S.A.

• Doxazosin CINFA 4 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN	4 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Laboratorios Cinfa S.A.

• Doxazosin Neo Aurovitas Spain 4 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN	4,00 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Aurovitas Spain, S.A.U.

• Doxazosin Neo Aurovitas Spain 8 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	9,7 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Aurovitas Spain, S.A.U.

• Doxazosin Neo Cinfa 4 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,85 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Laboratorios Cinfa S.A.

• Doxazosin Neo Cinfia 8 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	9,7 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Laboratorios Cinfa S.A.

• Doxazosin Neo Sandoz 4 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,85 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Sandoz Farmaceutica S.A.

• Doxazosin Neo Sandoz 8 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	9,7 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Sandoz Farmaceutica S.A.

• Doxazosin Neo Stada 4 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,85 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Laboratorio Stada S.L.

• Doxazosin Neo Stada 8 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	9,7 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Laboratorio Stada S.L.

• Doxazosin Neo Teva-Ratiopharm 4 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,85 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Teva Pharma S.L.U.

• Doxazosin Neo Teva-Ratiopharm 8 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	9,7 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Teva Pharma S.L.U.

• Doxazosin Neo Viatris 4 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,85 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Viatris Limited

• Doxazosin Neo Viatris 8 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	9,7 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Viatris Limited

• Doxazosin Neo Vir 4 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Industria Quimica Y Farmaceutica Vir S.A.

• Doxazosin Normon 2 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	2 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Laboratorios Normon S.A.

• Doxazosin Normon 4 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Laboratorios Normon S.A.

• Doxazosin Teva-Ratiopharm 2 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	2,426 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Teva Pharma S.L.U.

• Doxazosin Teva-Ratiopharm 4 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,852 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Teva Pharma S.L.U.

• Doxazosin Viatris Pharmaceuticals 4 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,852 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Viatris Limited

• Doxazosin Vir 2 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	2,425 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Industria Quimica Y Farmaceutica Vir S.A.

• Doxazosin Vir 4 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,85 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Industria Quimica Y Farmaceutica Vir S.A.

• Progandol 2 mg tablets

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	2,43 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Almirall S.A.

• Progandol 4 mg tablets

  Form: tablets

  Active substance	Dosage
  DOXAZOSIN MESYLATE	4,86 mg

  ATC code: C02C, C02CA, C02CA04

  Manufacturer: Almirall S.A.